| Income Statement |
| Total Revenue | 12.56B |
|
| Revenues (USD) | 12.56B |
| Cost of Revenue | 6.04B |
| Gross Profit | 6.52B |
| Operating Expenses | 2.33B |
| Research and Development Expense | 1.01B |
| Selling, General and Administrative Expense | 1.32B |
| Operating Income | 4.19B |
| Interest Expense | 175.69M |
| Income Tax Expense | 667.17M |
| Net Income | 3.40B |
| Net Income Common Stock | 3.40B |
| Net Income Common Stock (USD) | 3.40B |
| Consolidated Income | 3.40B |
| Earnings per Basic Share | 0.81 |
| Earnings per Basic Share (USD) | 0.81 |
| Earnings per Diluted Share | 0.80 |
| Earning Before Interest & Taxes (EBIT) | 4.24B |
| Earning Before Interest & Taxes (USD) | 4.24B |
| Weighted Average Shares | 4.19B |
| Weighted Average Shares Diluted | 4.26B |
| Balance Sheet |
| Cash and Equivalents | 9.10B |
| Cash and Equivalents (USD) | 9.10B |
| Investments | 28.68M |
| Investments Current | 28.68M |
| Current Assets | 13.85B |
| Property, Plant & Equipment Net | 2.40B |
| Total Assets | 58.45B |
| Debt Current | 2.48B |
| Total Debt | 14.31B |
| Current Liabilities | 12.13B |
| Debt Non-Current | 11.83B |
| Total Liabilities | 28.30B |
| Accumulated Retained Earnings (Deficit) | 50.97B |
| Accumulated Other Comprehensive Income | -97.12M |
| Shareholders Equity | 30.15B |
| Shareholders Equity (USD) | 30.15B |
| Assets Non-Current | 44.60B |
| Total Debt (USD) | 14.31B |
| Deferred Revenue | 1.80B |
| Goodwill and Intangible Assets | 33.84B |
| Liabilities Non-Current | 16.16B |
| Trade and Non-Trade Payables | 4.68B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.41B |
| Net Cash Flow from Financing | -4.67B |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.16B |
| Capital Expenditure | -218.64M |
| Issuance (Purchase) of Equity Shares | -4.65B |
| Net Cash Flow from Investing | -218.64M |
| Net Cash Flow from Operations | 1.74B |
| Effect of Exchange Rate Changes on Cash | -19.63M |
| Share Based Compensation | 131.31M |